Etibo 250mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Lapatinib (250mg)
Overview Etibo 250mg Tablet
Etilbo 250mg tablets are indicated for breast cancer management. This medication inhibits or reduces the proliferation of cancerous cells. It's administered either solely or in conjunction with other therapies to manage advanced breast cancer. Etilbo 250mg tablets should be ingested on an empty stomach, or one hour prior to, or two hours after, a meal. Dosage and treatment length depend on disease severity and therapeutic response. Adherence to the prescribed regimen is crucial to minimize adverse effects. Therapeutic benefits may not be evident for several weeks or months; discontinuation should only occur under medical guidance. Common side effects encompass nausea, headache, backache, and respiratory distress. Severe diarrhea necessitates increased fluid intake or medical consultation. Regular blood pressure monitoring may be required. Report severe headache, disorientation, visual disturbances, persistent nausea, or vomiting to your physician immediately. Liver function assessment is typically conducted before, during, and after treatment. Pre-treatment disclosure of liver or kidney impairment is essential. Interaction with other medications is possible; inform your healthcare provider of all concurrent medications. This medication is contraindicated during pregnancy and lactation. Reliable contraception is recommended for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Etibo 250mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Etibo 250mg Tablet
Malignant mammary tumor
Major Benefits of Etibo 250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Etibo 250mg Tablet should be taken on an empty stomach.
Common Side effects of Etibo 250mg Tablet:
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use Etibo 250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 250mg Etibo tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Etibo 250mg Tablet works:
Etibo 250mg tablets are an anti-cancer drug targeting HER2 and EGFR receptors, proteins that drive excessive cell growth. By blocking these receptors, it interrupts the cellular signaling cascades responsible for cancer cell proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Etibo 250mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Etibo 250mg Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Etibo 250mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Taking Etibo 250mg tablets might impair driving ability due to potential adverse effects.
KidneyCAUTION
Patients with severe kidney impairment should use Etibo 250mg Tablets cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Data on Etibo 250mg Tablet use in such patients is limited. Dosage alteration isn't advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with liver impairment should use Etibo 250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Data regarding its use in individuals with severe hepatic dysfunction is scarce.
What if you forget to take Etibo 250mg Tablet :
Omit a dose of Etibo 250mg Tablet? Seek medical advice.
Facts to Know About Etibo 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline Amine Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently